The European Medicines
Agency (EMA) and the US Food
and Drug Administration (FDA)
have announced that they have
significantly increased their level
of collaboration and sharing of
information to advance regulatory
excellence worldwide.
With almost daily interactions,
the two regulatory bodies have
structured their relationship around
“clusters”.
The focus of the cluster reviews
during their latest meeting was
pharmacovigilance, biosimilars,
paediatrics and veterinary
medicines they said.
Additional areas of interaction will
include rare diseases, inspections
and data integrity.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jul 15
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.